Skip to main content
Press release August 18, 2026

MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology

INNOVATE Corp. (VATE)

NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP. ® (NYSE: VATE) (“INNOVATE”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, and an equity method investment of
View original release